Insights

18-Oct-17  Prices of cardiac stents and knee implants in India have been cut by 70-80%, a result of government price caps, sounding alarm bells for international players and potentially undermining future foreign investments in the sector. [image: Times Now]

09-Oct-17 China will allow the use of some drugs and medical devices based on approval by foreign regulators, in a move to increase access to its healthcare market, improve access to treatments, and streamline the approval process. [image: Think Advisor]

05-Oct-17 A Chinese University department head sees opportunity as Hong Kong braces for 30% of its population to be older than 65, saying it should seize opportunities to develop biomedical technology that could boost the economy and provide better healthcare. [image: South China Morning Post]

05-Oct-17 Chinese drug firm Fosun Pharma has acquired a 74% controlling interest of Hyderabad based Gland Pharma at a valuation of USD1.1 bn. The new owners intend to keep present management in charge of the day-to-day running of the company. [image: Gland Pharma Limited]